Envestnet Asset Management Inc. Has $8.70 Million Holdings in Doximity, Inc. (NASDAQ:DOCS)

Envestnet Asset Management Inc. raised its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 19.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 162,905 shares of the company's stock after purchasing an additional 27,001 shares during the quarter. Envestnet Asset Management Inc. owned 0.09% of Doximity worth $8,697,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Global Retirement Partners LLC grew its position in shares of Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after acquiring an additional 440 shares in the last quarter. UMB Bank n.a. raised its stake in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after acquiring an additional 235 shares in the last quarter. Larson Financial Group LLC raised its stake in Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after acquiring an additional 250 shares in the last quarter. Optimum Investment Advisors bought a new stake in Doximity during the 4th quarter valued at $43,000. Finally, Morse Asset Management Inc bought a new stake in Doximity during the 3rd quarter valued at $46,000. Institutional investors and hedge funds own 87.19% of the company's stock.

Analyst Ratings Changes

Several analysts have weighed in on DOCS shares. Bank of America lifted their target price on Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a research note on Monday, January 6th. Truist Financial dropped their price target on shares of Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a research report on Thursday, April 10th. Canaccord Genuity Group lifted their price objective on shares of Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a research note on Friday, February 7th. KeyCorp lowered their price objective on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Finally, Wells Fargo & Company reaffirmed an "equal weight" rating on shares of Doximity in a research note on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $65.00.

Insider Buying and Selling

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares of the company's stock, valued at $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 37.40% of the stock is currently owned by insiders.

Doximity Price Performance

DOCS stock traded up $1.03 during mid-day trading on Thursday, reaching $55.25. The company had a trading volume of 311,690 shares, compared to its average volume of 1,985,854. The stock has a 50 day simple moving average of $61.54 and a two-hundred day simple moving average of $55.93. The company has a market capitalization of $10.31 billion, a price-to-earnings ratio of 55.19, a PEG ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.